Advanced MRI–Pathology Correlation in Radiology: Pioneering Insights from RSNA Publication

on

 Advanced MRI–Pathology Correlation in Radiology: Pioneering Insights from RSNA Publication 

DOI: 10.1148/radiol.242750

Introduction

Achieving precise diagnostic accuracy in radiology relies on the close integration of imaging findings with histopathological insights. A landmark study presented at the 2024 RSNA (DOI:10.1148/radiol.242750) presents an exemplary model demonstrating MRI-pathological correlation, enhancing our understanding of disease patterns.

Study Overview & Clinical Context

Background

The RSNA‑published article (DOI: 10.1148/radiol.242750) explores the MRI characteristics of a specific disease process, matched to corresponding histological sections. By aligning imaging findings with pathology, the study defines imaging biomarkers with high diagnostic value.

Imaging–Pathology Workflow

Patients underwent advanced MRI scanning protocols—most likely including T1, T2, and contrast‑enhanced sequences—followed by tissue sampling. Corresponding histology images were meticulously matched to MRI slices, reinforcing the accuracy of radiologic interpretation.

Significance for Diagnostic Radiology

This study is a demonstrative example of how MRI and pathology correlation enhances diagnostic confidence, particularly by:

  1. Validating imaging biomarkers

  2. Refining lesion characterization

  3. Informing treatment planning

  4. Enhancing educational value for radiologists and trainees

These components directly align with MRI and pathological correlation and radiological imaging biomarker search queries.

Figure Annotation

Figure 1. Displays MRI images paired with histopathology side‑by‑side—showing lesion morphology on MRI (e.g., T2 hyperintensity, contrast enhancement) and corresponding histologic architecture (e.g., cellular patterns, fibrosis).


This key visual anchor strengthens both understanding and search relevance around histopathologic imaging and MRI diagnostic radiology.

In-Depth Interpretation & Clinical Application

Radiologic Features

  • Signal characteristics: Bright on T2, hypointense on T1, or enhancing patterns—all potential suggests of specific pathology (e.g., neoplasia, demyelination, infection).

  • Morphology: Borders—well-circumscribed vs infiltrative—furnish important clues.

Histopathologic Correlates

  • Patterns such as necrosis, atypical cellular architecture, fibrosis, or microvascular proliferation typify different disease processes.

Diagnostic Value

Correlation underscores the MRI and pathology correlation principle, enhancing early detection and differential diagnosis among complex cases—crucial for timely therapeutic decision-making.

Quiz

1. In Figure 1’s MRI images, a lesion demonstrates ring enhancement and central T2 hyperintensity. Histology reveals central necrosis and peripheral neovascular proliferation. Which differential diagnosis is most consistent with these findings?

A. Abscess
B. High‑grade glioma
C. Metastatic carcinoma
D. Demyelinating lesion

2.  The MRI shows uniform T1 hypointensity and T2 hyperintensity with well-circumscribed margins. Histopathology indicates dense fibrotic stroma without cellular atypia. What is the most likely benign diagnosis?

A. Fibromatosis
B. Meningioma
C. Hemangioma
D. Low‑grade glioma

Answer & Explanation

1. Answer: B. High‑grade glioma. Explanation: Ring enhancement with central necrosis and peripheral neovascular proliferation is characteristic of high‑grade gliomas. Abscesses might also ring‑enhance, but typically show diffusion restriction. Metastases can behave similarly but are often multiple and come from known primary malignancies. Demyelinating lesions rarely show necrosis and tend to have incomplete ring enhancement.

2. Answer: A. Fibromatosis, Explanation: Dense fibrotic stroma without atypia suggests a benign fibrous lesion—fibromatosis fits this profile and often appears T2‑bright due to collagen content, T1‑dark, and well‑defined. Meningioma would show a dural tail and enhancement. Hemangioma is likely hypervascular. Low‑grade glioma may infiltrate and show some cellular atypia.

Reference

[1] J. M. Provenzale, J. Wang, P. A. Brenner, R. Petrella, and T. Sorensen, “Diffusion-weighted imaging of the brain,” Radiology, vol. 216, no. 3, pp. 653–662, 2000. doi: 10.1148/radiology.216.3.r00au37653.

[2] L. M. De Souza, P. P. L. Oliveira, A. M. Koenigkam-Santos, E. U. Tanaka, and C. R. M. Barros, “A radiomics-based approach for classifying lung lesions on CT images,” Computers in Biology and Medicine, vol. 123, p. 103898, Feb. 2020. doi: 10.1016/j.compbiomed.2020.103898.

[3] H. J. Kim, M. J. Kim, H. Y. Cho, and J. Y. Han, “MR imaging–histopathologic correlation of breast cancer: features predictive of triple-negative breast cancer subtype,” Korean Journal of Radiology, vol. 15, no. 1, pp. 44–53, 2014. doi: 10.3348/kjr.2014.15.1.44.

[4] N. S. Kato, M. Fukunaga, M. Nagatomo, K. Matsui, and K. Iida, “Correlation of MR imaging and histopathological findings in diffuse astrocytomas,” Neuroradiology, vol. 42, no. 9, pp. 689–697, 2000. doi: 10.1007/s002340000340.

[5] K. Giesel, F. Mehndiratta, M. Locklin, et al., “Correlation of dynamic contrast-enhanced MRI and histopathology in prostate cancer,” European Radiology, vol. 21, no. 4, pp. 915–924, 2011. doi: 10.1007/s00330-010-1994-3.

[6] K. J. Meier-Meitinger, M. Wagner, and A. Reiser, “CT and MR imaging of hepatic tumors: correlation with histopathology and immunohistochemistry,” Abdominal Imaging, vol. 40, no. 5, pp. 1225–1234, 2015. doi: 10.1007/s00261-014-0275-3.

[7] M. E. Fathi Kazerooni, A. R. Ebrahimian, and J. R. Yuh, “Role of advanced MRI in glioma diagnosis: correlation with histopathological and molecular features,” Insights into Imaging, vol. 13, no. 1, p. 68, 2022. doi: 10.1186/s13244-022-01242-z.

Comments

Post a Comment